Recombinant Human GRB2 Protein，His

GRB2 (Growth Factor Receptor-Bound Protein 2) is a pivotal adaptor protein that plays a critical role in various cellular processes, including proliferation, differentiation, and survival, primarily by mediating signaling pathways activated by receptor tyrosine kinases. Its structure features an SH2 domain that binds phosphorylated tyrosine residues and two SH3 domains that interact with proline-rich motifs in other proteins, facilitating the assembly of signaling complexes. The dysregulation of GRB2 has been implicated in several diseases, particularly cancer, where it contributes to oncogenic signaling pathways. Therefore, the recombinant expression and purification of GRB2 have garnered significant research interest as a means to elucidate its functional mechanisms and regulatory roles. By producing GRB2 in a recombinant system, researchers can obtain large quantities of the protein for structural studies, functional assays, and drug screening. Additionally, understanding the interaction of GRB2 with its binding partners can unveil potential therapeutic targets for intervention in diseases characterized by disturbed growth factor signaling. Efforts to study GRB2 at the molecular level have the potential to provide insights into its contribution to cellular signaling networks and the pathogenesis of proliferative disorders, thereby enhancing our knowledge of targeted therapies in oncology and beyond.